Evidence map›Paper›PMID 33574244›Full record

ArticleTranslational psychiatry2021

Identification and functional characterization of the extremely long allele of the serotonin transporter-linked polymorphic region.

Tempei Ikegame, Yosuke Hidaka, Yutaka Nakachi, Yui Murata, Risa Watanabe, Hiroko Sugawara, Tatsuro Asai, Emi Kiyota, Takeo Saito, Masashi Ikeda and 10 more

Abstract read
In one paragraph

Article in Translational psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Tempei Ikegame *Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Yosuke Hidaka *Department of Neuropsychiatry, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Yutaka NakachiDepartment of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Yui MurataDepartment of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Risa WatanabeDepartment of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Hiroko SugawaraDepartment of Psychiatry, Kansai Rosai Hospital, Hyogo, Japan.
Tatsuro AsaiDepartment of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Emi KiyotaDepartment of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Takeo SaitoDepartment of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan.
Masashi IkedaDepartment of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan.ORCID 0000-0001-6237-2449
Tsukasa SasakiLaboratory of Health Education, Graduate School of Education, The University of Tokyo, Tokyo, Japan.
Mamoru HashimotoDepartment of Psychiatry, Graduate School of Medicine Osaka University, Osaka, Japan.
Tomohisa IshikawaDepartment of Neuropsychiatry, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Minoru TakebayashiDepartment of Neuropsychiatry, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Nakao IwataDepartment of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan.ORCID 0000-0003-3189-6076
Chihiro KakiuchiDepartment of Psychiatry and Behavioral Science, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
Tadafumi KatoDepartment of Psychiatry and Behavioral Science, Graduate School of Medicine, Juntendo University, Tokyo, Japan.ORCID 0000-0001-7856-3952
Kiyoto KasaiDepartment of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Miki BundoDepartment of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan. bundo@kumamoto-u.ac.jp.
Kazuya IwamotoDepartment of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan. iwamotok@kumamoto-u.ac.jp.ORCID 0000-0002-1780-692X

Funding

Japan Agency for Medical Research and Development (AMED) JP20dm0107097Japan Agency for Medical Research and Development (AMED) JP20dm0207069Japan Agency for Medical Research and Development (AMED) JP20dm0207074Japan Agency for Medical Research and Development (AMED) JP20dm0307001Japan Agency for Medical Research and Development (AMED) JP20dm0307004Japan Agency for Medical Research and Development (AMED) JP20km0405201Japan Agency for Medical Research and Development (AMED) JP20km0405208
6 · The paper itself

Abstract

SLC6A4, which encodes the serotonin transporter, has a functional polymorphism called the serotonin transporter-linked polymorphic region (5-HTTLPR). The 5-HTTLPR consists of short (S) and long (L) alleles, each of which has 14 or 16 tandem repeats. In addition, the extralong (XL) and other rare alleles have been reported in 5-HTTLPR. Although they are more frequent in Asian and African than in other populations, the extent of variations and allele frequencies (AFs) were not addressed in a large population. Here, we report the AFs of the rare alleles in a large number of Japanese subjects (N = 2894) consisting of two cohorts. The first cohort (case-control study set, CCSS) consisted of 1366 subjects, including 485 controls and 881 patients with psychosis (bipolar disorder or schizophrenia). The second cohort (the Arao cohort study set, ACSS) consisted of 1528 elderly subjects. During genotyping, we identified 11 novel 5-HTTLPR alleles, including 3 XL alleles. One novel allele had the longest subunit ever reported, consisting of 28 tandem repeats. We named this XL

Indexed as

Serotonin Plasma Membrane Transport ProteinsAgedAllelesCase-Control StudiesCohort StudiesGenotypeHumansSerotonin Plasma Membrane Transport ProteinsSLC6A4 protein, human

Identifiers

PMID33574244
PMCPMC7878853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.